Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 318,345
  • Shares Outstanding, K 101,062
  • Annual Sales, $ 45,600 K
  • Annual Income, $ -46,530 K
  • 60-Month Beta 2.46
  • Price/Sales 7.00
  • Price/Cash Flow N/A
  • Price/Book 1.32
Trade FBIO with:

Options Overview Details

View History
  • Implied Volatility 84.08%
  • Historical Volatility 48.95%
  • IV Percentile 48%
  • IV Rank 33.70%
  • IV High 160.39% on 04/09/21
  • IV Low 45.30% on 07/21/21
  • Put/Call Vol Ratio 1.00
  • Today's Volume 10
  • Volume Avg (30-Day) 100
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 3,677
  • Open Int (30-Day) 4,756

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.11
  • Number of Estimates 6
  • High Estimate -0.05
  • Low Estimate -0.16
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +45.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.06 +9.15%
on 08/23/21
3.48 -4.02%
on 09/02/21
+0.28 (+9.15%)
since 08/20/21
3-Month
2.80 +19.29%
on 08/16/21
3.80 -12.11%
on 06/28/21
-0.18 (-5.11%)
since 06/22/21
52-Week
2.12 +57.55%
on 11/02/20
6.10 -45.25%
on 04/12/21
-1.03 (-23.57%)
since 09/22/20

Most Recent Stories

More News
Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will...

CKPT : 3.43 (+4.89%)
FBIO : 3.34 (+6.03%)
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will...

CKPT : 3.43 (+4.89%)
FBIO : 3.34 (+6.03%)
Mustang Bio to Participate in Three September 2021 Investor Conferences

Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic...

MBIO : 2.71 (+1.12%)
FBIO : 3.34 (+6.03%)
Fortress Biotech to Participate in Three September 2021 Investor Conferences

Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress"), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product...

FBIO : 3.34 (+6.03%)
Fortress Biotech (FBIO) Reports Q2 Loss, Tops Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of 71.43% and 29.11%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

FBIO : 3.34 (+6.03%)
Fortress Biotech: Q2 Earnings Snapshot

NEW YORK (AP) _ Fortress Biotech Inc. (FBIO) on Monday reported a loss of $3.5 million in its second quarter.

FBIO : 3.34 (+6.03%)
Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights

Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic...

MBIO : 2.71 (+1.12%)
FBIO : 3.34 (+6.03%)
Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights

Net revenue for second quarter of 2021 increased 89% year-over-year to $17.8 million, a quarterly record

FBIO : 3.34 (+6.03%)
Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the second quarter ended June 30, 2021.

CKPT : 3.43 (+4.89%)
FBIO : 3.34 (+6.03%)
Fortress Biotech (FBIO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FBIO : 3.34 (+6.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

See More

Key Turning Points

3rd Resistance Point 3.63
2nd Resistance Point 3.50
1st Resistance Point 3.42
Last Price 3.34
1st Support Level 3.21
2nd Support Level 3.08
3rd Support Level 3.01

See More

52-Week High 6.10
Fibonacci 61.8% 4.58
Fibonacci 50% 4.11
Fibonacci 38.2% 3.64
Last Price 3.34
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar